IDEAYA Announces First Patient In for Company Sponsored Phase 2 Clinical Trial Evaluating Darovasertib in Neo Adjuvant Uveal Melanoma

Wednesday, August 16, 2023 1 min read

Key Takeaway: IDEAYA Announces First Patient In for Company Sponsored Phase 2 Clinical Trial Evaluating Darovasertib in Neo Adjuvant Uveal Melanoma

Full Press Release Details

IDEAYA Announces First Patient In for Company Sponsored Phase 2 Clinical Trial Evaluating Darovasertib in Neo Adjuvant Uveal Melanoma.

FDA Calendar

BPW Portfolio

Historical FDA Calendar

Market Movers

Biotech Earning Calendar

Historical PDUFA Dates

PDUFA Calendar

Conference Calendar

IPO

Catalyst Sync™

Hedge Fund Screener

Company Screener

All Stocks Holdings

Heat-Map

Inside Trades

Biotech Analyst Ratings

M&A Tracker

News

Blogs

Modality Leaderboard

Discord

User Guide

Biotech Investing 101

Recent Updates

Recently added Catalysts

Full Press Release Details